Literature DB >> 18355921

Is there an association between hypothyroidism and open-angle glaucoma in an elderly population? An epidemiologic study.

Stephen P Motsko1, Judith K Jones.   

Abstract

PURPOSE: There have been conflicting reports pertaining to the association between hypothyroidism and open-angle glaucoma (OAG). The purpose of this study was to assess the hypothesized association between preexisting hypothyroidism and development of OAG in a population-based setting.
DESIGN: Case-control study. PARTICIPANTS: The study population and controls were taken from all patients in a large US managed care database aged >or=60 years with 4 years of continuous eligibility dating from January 1, 2001, through December 31, 2004.
METHODS: A total of 4728 newly diagnosed OAG patients were matched with 14 184 controls (3:1 matching) based on age and gender. MAIN OUTCOME MEASURES: Conditional logistic regression was used to assess the relationship between hypothyroidism and OAG while controlling for various risk factors (ischemic heart disease, cerebrovascular disease, hyperlipidemia, hypertension, arterial disease, diabetes, and migraines).
RESULTS: Based on a diagnosis of hypothyroidism or use of a thyroid replacement therapy, prior hypothyroidism was found in 815 (17.2%) OAG subjects and in 2498 (17.6%) control subjects. After adjusting for the specified risk factors, patients with OAG were not found to be associated with a prior hypothyroid diagnosis when compared with control subjects (odds ratio, 0.93; 95% confidence interval, 0.85-1.01).
CONCLUSIONS: An association between prior hypothyroidism and OAG development was not found. The large proportion of patients receiving thyroid replacement therapy may have negated any OAG-related consequences of hypothyroidism.

Entities:  

Mesh:

Year:  2008        PMID: 18355921     DOI: 10.1016/j.ophtha.2008.01.016

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  The effect of orbital decompression surgery on refraction and intraocular pressure in patients with thyroid orbitopathy.

Authors:  J H Norris; J J Ross; M Kazim; D Selva; R Malhotra
Journal:  Eye (Lond)       Date:  2012-01-20       Impact factor: 3.775

2.  The association between thyroid problems and glaucoma.

Authors:  J M Cross; C A Girkin; C Owsley; G McGwin
Journal:  Br J Ophthalmol       Date:  2008-10-16       Impact factor: 4.638

3.  Investigation of the choroidal thickness in patients with hypothyroidism.

Authors:  Fatih Ulas; Ümit Dogan; Oguz Dikbas; Serdal Celebi; Asena Keles
Journal:  Indian J Ophthalmol       Date:  2015-03       Impact factor: 1.848

Review 4.  Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis.

Authors:  Minwen Zhou; Wei Wang; Wenbin Huang; Xiulan Zhang
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

5.  Glaucomatous Optic Nerve Changes and Thyroid Dysfunction in an Urban South Korean Population.

Authors:  Yu Sam Won; Da Yeong Kim; Joon Mo Kim
Journal:  J Ophthalmol       Date:  2017-05-02       Impact factor: 1.909

Review 6.  Hypothyroidism as a risk factor for open angle glaucoma: A systematic review and meta-analysis.

Authors:  Shiming Wang; Yue Liu; Guangying Zheng
Journal:  PLoS One       Date:  2017-10-25       Impact factor: 3.240

7.  Meta-Analysis of Dyslipidemia and Blood Lipid Parameters on the Risk of Primary Open-Angle Glaucoma.

Authors:  Guimei Huang; Jiayi Wang; Lei Li; Yuan Gao; Yijie Yan
Journal:  Comput Math Methods Med       Date:  2022-09-21       Impact factor: 2.809

8.  Hypothyroidism and Glaucoma in The United States.

Authors:  Caitlin Kakigi; Toshimitsu Kasuga; Sophia Y Wang; Kuldev Singh; Yoshimune Hiratsuka; Akira Murakami; Shan C Lin
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

Review 9.  Migraine as a risk factor for primary open angle glaucoma: A systematic review and meta-analysis.

Authors:  Chang Xu; Jingjing Li; Zhi Li; Xiaochun Mao
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.